Two Trial Halts In A Row – Gilead Sciences Stops Late Stage COVID-19 Study
Gilead Sciences Inc (NASDAQ: GILD) said it has
Gilead Sciences Adapts to Economic Shifts to Support Investor Confidence
By the end of today, September 28, 2023, Gilead Sciences (NASDAQ:GILD) is set to deliver a dividend payout of $0.75 per share, equating to an annualized dividend yield of 3.96%.
Wall Street’s Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
How Is The Market Feeling About Gilead Sciences?
Gilead Sciences’s (NYSE:GILD) short percent of float has fallen 6.82% since its last report. The company recently reported…
Gilead Sciences Unusual Options Activity
A whale with a lot of money to spend has taken a noticeably bullish stance on Gilead Sciences.…
Gilead’s Breast Cancer Drug Shows Promise When Combined With Merck’s Treatment
Gilead Sciences Inc (NASDAQ: GILD) revealed early data from its open-label, Phase 2 EVOKE-02 study evaluating Trodelvy.
Gilead Earlier Announced Phase 2 Evoke-02 Study Of Trodelvy (Sacituzumab Govitecan-hziy) In Combination With Keytruda (Pembrolizumab) Demonstrates Clinical Activity In First-line Metastatic Non-small Cell Lung Cancer
Gilead Sciences, Inc. (NASDAQ:GILD) today announced promising early data from the global, open-label, Phase 2 EVOKE-02 study evaluating Trodelvy® (sacituzumab govitecan-hziy) in combination with Merck’s
How To Earn $500 A Month From Gilead Sciences Stock
Shares of Gilead Sciences, Inc (NASDAQ: GILD) are trading higher during Friday’s trading session, bolstered by the Bank of America Securities bullish outlook on the stock.
Infectious Disease Player Vir Biotech Has Limited Near Term Upside, Analyst Downgrades
BofA Securities has downgraded Vir Biotechnology Inc (NASDAQ: VIR) to Neutral from Buy with a price target of $14,
Gilead Sciences Shares Trade Higher After Bullish Analyst Upgrades Stock
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) are trading higher into Friday’s trading session after Bank of America Securities upgraded the stock, highlighting an underappreciated growth potential in its core HIV business and emerging hem